Advocacy News Archives

With a large majority of state legislatures adjourned for the year and Congress in August recess, it is a great time to look back at the first half of 2024.

This week, we wished a heartfelt farewell to our colleague and friend, Kandis McClure, FSMB’s Director of Federal Advocacy and Policy.

On June 27, the Supreme Court dismissed Moyle v. United States, effectively allowing abortions in medical emergencies in Idaho and reinstating a lower-court ruling that had halted Idaho’s

Last week, more than 175 individuals from state medical boards professional associations, medical education, accreditation and certification organizations gathered in Washington, DC to discuss

Tomorrow, the Ohio Senate Health Committee will hold a hearing at 9:30 am ET on HB 73, which would permit prescribers to issue prescriptions, and pharmacists to dispense (FDA-approved) off-label

On Tuesday, an FDA advisory committee found that MDMA, commonly known as ecstasy, is not an effective treatment for post-traumatic stress disorder, voting that the combination of therapy

Minnesota Governor Tim Walz enacted HF 5247 on May 24 and Tennessee Governor Bill Lee enacted SB 1727 on May 28, entering both states into the PA Licensure Compact.

The House Ways and Means Committee will meet at 10:30am EST today to consider a handful of proposals that would extend many of the telehealth flexibilities granted to Medicare beneficiaries

The FSMB’s House of Delegates adopted several policies during its annual meeting on April 20th, addressing timely topics relevant to medical regulation, including opioid prescribing, opioid

Last week, the FSMB held its annual meeting in Nashville, Tennessee with record attendance from state medical board representatives and other stakeholders in medical